Clement Blount Sledge, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Knee Prosthesis | 22 | 2004 | 395 | 1.230 |
Why?
|
| Hip Prosthesis | 29 | 1997 | 921 | 1.150 |
Why?
|
| Joint Prosthesis | 18 | 2004 | 253 | 0.710 |
Why?
|
| Synovial Membrane | 25 | 1998 | 532 | 0.610 |
Why?
|
| Radioisotopes | 11 | 1995 | 499 | 0.600 |
Why?
|
| Arthritis, Rheumatoid | 40 | 1998 | 3763 | 0.580 |
Why?
|
| Dysprosium | 10 | 1994 | 24 | 0.500 |
Why?
|
| Cartilage | 14 | 1991 | 806 | 0.420 |
Why?
|
| Knee Joint | 26 | 2003 | 1676 | 0.420 |
Why?
|
| Arthroplasty, Replacement, Knee | 11 | 2006 | 1393 | 0.380 |
Why?
|
| Hip Joint | 17 | 1999 | 1014 | 0.360 |
Why?
|
| Synovitis | 8 | 1998 | 217 | 0.320 |
Why?
|
| Osteoarthritis | 21 | 2003 | 1063 | 0.310 |
Why?
|
| Cartilage, Articular | 16 | 1998 | 1099 | 0.250 |
Why?
|
| Ferric Compounds | 9 | 1994 | 378 | 0.220 |
Why?
|
| Bone Cements | 8 | 2001 | 325 | 0.220 |
Why?
|
| Orthopedics | 5 | 1995 | 898 | 0.210 |
Why?
|
| Femur | 10 | 1990 | 1307 | 0.200 |
Why?
|
| Evaluation Studies as Topic | 13 | 1996 | 1625 | 0.190 |
Why?
|
| Patella | 7 | 1999 | 315 | 0.190 |
Why?
|
| Arthritis | 8 | 1993 | 680 | 0.190 |
Why?
|
| Proteoglycans | 11 | 1990 | 803 | 0.180 |
Why?
|
| Polyethylenes | 5 | 2004 | 290 | 0.180 |
Why?
|
| Prosthesis Failure | 13 | 2004 | 1204 | 0.160 |
Why?
|
| Shoulder Joint | 5 | 1990 | 742 | 0.150 |
Why?
|
| Interleukin-1 | 7 | 1992 | 1248 | 0.140 |
Why?
|
| Activities of Daily Living | 9 | 2004 | 2421 | 0.140 |
Why?
|
| Cyclic AMP | 3 | 1991 | 1463 | 0.130 |
Why?
|
| Postoperative Complications | 23 | 1999 | 15633 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2002 | 1413 | 0.130 |
Why?
|
| Osseointegration | 2 | 2001 | 274 | 0.120 |
Why?
|
| Reoperation | 16 | 2004 | 4303 | 0.120 |
Why?
|
| Endotoxins | 2 | 1988 | 520 | 0.120 |
Why?
|
| Culture Techniques | 14 | 1988 | 531 | 0.120 |
Why?
|
| Elbow Joint | 2 | 1993 | 359 | 0.120 |
Why?
|
| Radiography | 19 | 1999 | 6965 | 0.120 |
Why?
|
| Prosthesis Design | 9 | 1999 | 2115 | 0.120 |
Why?
|
| Tibia | 8 | 2001 | 1070 | 0.110 |
Why?
|
| Hip Dislocation | 2 | 1995 | 247 | 0.110 |
Why?
|
| Methylmethacrylates | 2 | 1984 | 67 | 0.110 |
Why?
|
| Arthritis, Experimental | 3 | 1989 | 291 | 0.110 |
Why?
|
| Sodium Pertechnetate Tc 99m | 3 | 1988 | 54 | 0.110 |
Why?
|
| Hydrocortisone | 6 | 1988 | 1819 | 0.110 |
Why?
|
| Cattle | 12 | 1997 | 3849 | 0.110 |
Why?
|
| Epiphyses | 4 | 1981 | 190 | 0.100 |
Why?
|
| Collagen | 10 | 1998 | 2638 | 0.100 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 1992 | 32 | 0.100 |
Why?
|
| Pain | 13 | 2004 | 5073 | 0.100 |
Why?
|
| Acetabulum | 1 | 1996 | 542 | 0.100 |
Why?
|
| Glycosaminoglycans | 5 | 1998 | 607 | 0.100 |
Why?
|
| Joints | 3 | 1990 | 322 | 0.100 |
Why?
|
| Ankle Joint | 2 | 1994 | 446 | 0.090 |
Why?
|
| beta-Thalassemia | 1 | 1993 | 236 | 0.090 |
Why?
|
| Managed Care Programs | 1 | 1996 | 940 | 0.090 |
Why?
|
| Biocompatible Materials | 4 | 2004 | 1685 | 0.090 |
Why?
|
| Dinoprostone | 4 | 1992 | 597 | 0.090 |
Why?
|
| Radiometry | 2 | 1995 | 813 | 0.090 |
Why?
|
| Synovial Fluid | 5 | 1993 | 393 | 0.090 |
Why?
|
| Rhenium | 1 | 1990 | 14 | 0.090 |
Why?
|
| Follow-Up Studies | 25 | 2004 | 39106 | 0.090 |
Why?
|
| Rabbits | 15 | 1999 | 4772 | 0.090 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1995 | 1192 | 0.080 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1991 | 155 | 0.080 |
Why?
|
| Osteoarthritis, Hip | 1 | 1993 | 409 | 0.080 |
Why?
|
| Sickness Impact Profile | 2 | 2003 | 299 | 0.080 |
Why?
|
| Middle Aged | 52 | 2006 | 220921 | 0.070 |
Why?
|
| Aged | 47 | 2006 | 169310 | 0.070 |
Why?
|
| Terminology as Topic | 2 | 1995 | 1530 | 0.070 |
Why?
|
| Range of Motion, Articular | 4 | 2003 | 1588 | 0.070 |
Why?
|
| Paraplegia | 1 | 1987 | 161 | 0.070 |
Why?
|
| Polymethyl Methacrylate | 2 | 2004 | 131 | 0.070 |
Why?
|
| Osteoarthritis, Knee | 3 | 2006 | 1234 | 0.070 |
Why?
|
| Humans | 96 | 2006 | 761596 | 0.070 |
Why?
|
| Nerve Compression Syndromes | 1 | 1987 | 160 | 0.060 |
Why?
|
| Shoulder | 1 | 1987 | 300 | 0.060 |
Why?
|
| Titanium | 3 | 2004 | 485 | 0.060 |
Why?
|
| Movement | 7 | 1990 | 1478 | 0.060 |
Why?
|
| Equipment Failure | 5 | 1990 | 578 | 0.060 |
Why?
|
| Tissue Distribution | 5 | 1998 | 2264 | 0.060 |
Why?
|
| Liposomes | 1 | 1988 | 783 | 0.060 |
Why?
|
| Adult | 39 | 2006 | 221210 | 0.060 |
Why?
|
| Gait | 4 | 1991 | 814 | 0.050 |
Why?
|
| Health Care Costs | 1 | 1996 | 3242 | 0.050 |
Why?
|
| Pain Measurement | 3 | 2003 | 3551 | 0.050 |
Why?
|
| Dogs | 9 | 1998 | 3839 | 0.050 |
Why?
|
| Complement Activation | 1 | 2004 | 445 | 0.050 |
Why?
|
| Patient Satisfaction | 4 | 2006 | 3462 | 0.050 |
Why?
|
| Methods | 4 | 1990 | 1067 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 1991 | 3162 | 0.050 |
Why?
|
| Iron | 3 | 1986 | 1793 | 0.050 |
Why?
|
| Computer Simulation | 1 | 1995 | 6241 | 0.050 |
Why?
|
| Complement System Proteins | 2 | 2004 | 735 | 0.050 |
Why?
|
| Hip | 2 | 1988 | 255 | 0.050 |
Why?
|
| Acid Phosphatase | 4 | 1974 | 139 | 0.050 |
Why?
|
| Osteitis | 1 | 2001 | 33 | 0.050 |
Why?
|
| Male | 48 | 2006 | 360846 | 0.050 |
Why?
|
| Polyethylene | 2 | 2001 | 185 | 0.050 |
Why?
|
| Aged, 80 and over | 14 | 2006 | 58984 | 0.050 |
Why?
|
| Arthroplasty | 3 | 1980 | 313 | 0.050 |
Why?
|
| Arthrodesis | 1 | 1982 | 186 | 0.050 |
Why?
|
| Bone Resorption | 4 | 1990 | 723 | 0.040 |
Why?
|
| Animals | 43 | 2001 | 168475 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 2004 | 402 | 0.040 |
Why?
|
| Time Factors | 13 | 2002 | 39969 | 0.040 |
Why?
|
| Surgical Wound Infection | 4 | 1985 | 1529 | 0.040 |
Why?
|
| Locomotion | 4 | 1990 | 388 | 0.040 |
Why?
|
| Bone Substitutes | 1 | 2001 | 236 | 0.040 |
Why?
|
| Female | 48 | 2006 | 392705 | 0.040 |
Why?
|
| Cost Control | 2 | 1996 | 628 | 0.040 |
Why?
|
| Bone Lengthening | 1 | 1978 | 20 | 0.040 |
Why?
|
| Injections, Intra-Articular | 5 | 1988 | 280 | 0.040 |
Why?
|
| Bacterial Infections | 3 | 1984 | 1391 | 0.040 |
Why?
|
| Ossification, Heterotopic | 1 | 2001 | 235 | 0.040 |
Why?
|
| Implants, Experimental | 1 | 1999 | 99 | 0.040 |
Why?
|
| Pain, Postoperative | 2 | 2006 | 1740 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 1988 | 2161 | 0.040 |
Why?
|
| Radius | 1 | 1981 | 441 | 0.040 |
Why?
|
| Hypotension | 1 | 1984 | 879 | 0.040 |
Why?
|
| Regeneration | 3 | 1997 | 1512 | 0.040 |
Why?
|
| Foreign-Body Reaction | 3 | 1996 | 157 | 0.040 |
Why?
|
| Cell Transplantation | 2 | 1998 | 472 | 0.040 |
Why?
|
| Joint Diseases | 2 | 1998 | 459 | 0.040 |
Why?
|
| Wound Healing | 3 | 2001 | 2805 | 0.040 |
Why?
|
| Radionuclide Imaging | 3 | 1987 | 1972 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1996 | 2186 | 0.040 |
Why?
|
| Cadaver | 2 | 1995 | 1358 | 0.040 |
Why?
|
| Organometallic Compounds | 2 | 1993 | 647 | 0.030 |
Why?
|
| Corrosion | 1 | 1996 | 26 | 0.030 |
Why?
|
| Hardness | 1 | 1996 | 35 | 0.030 |
Why?
|
| Foreign-Body Migration | 1 | 1999 | 219 | 0.030 |
Why?
|
| Life Tables | 1 | 1997 | 364 | 0.030 |
Why?
|
| Metals | 2 | 1993 | 719 | 0.030 |
Why?
|
| Elbow | 1 | 1977 | 130 | 0.030 |
Why?
|
| Osteochondritis | 1 | 1996 | 23 | 0.030 |
Why?
|
| Hyperplasia | 3 | 1996 | 1152 | 0.030 |
Why?
|
| Hip Fractures | 1 | 1984 | 988 | 0.030 |
Why?
|
| Porphyrins | 1 | 1998 | 352 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 1998 | 285 | 0.030 |
Why?
|
| Beta Particles | 1 | 1995 | 51 | 0.030 |
Why?
|
| Osteotomy | 2 | 1978 | 837 | 0.030 |
Why?
|
| Models, Structural | 1 | 1995 | 340 | 0.030 |
Why?
|
| Documentation | 3 | 1991 | 897 | 0.030 |
Why?
|
| Recurrence | 3 | 1995 | 8466 | 0.030 |
Why?
|
| Lysosomes | 4 | 1973 | 924 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1988 | 646 | 0.030 |
Why?
|
| Mental Recall | 1 | 2001 | 1221 | 0.030 |
Why?
|
| Dextrans | 3 | 1987 | 574 | 0.030 |
Why?
|
| Walking | 2 | 2006 | 1198 | 0.030 |
Why?
|
| Lymphatic Diseases | 1 | 1996 | 320 | 0.030 |
Why?
|
| Prostaglandins | 2 | 1987 | 398 | 0.030 |
Why?
|
| Cells, Cultured | 8 | 1997 | 18966 | 0.030 |
Why?
|
| Fracture Fixation | 1 | 1996 | 366 | 0.030 |
Why?
|
| Photosensitizing Agents | 1 | 1998 | 623 | 0.030 |
Why?
|
| Pronation | 1 | 1993 | 52 | 0.030 |
Why?
|
| Radiation Dosage | 3 | 1995 | 1958 | 0.030 |
Why?
|
| Supination | 1 | 1993 | 70 | 0.030 |
Why?
|
| Treatment Outcome | 9 | 2006 | 64685 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1993 | 130 | 0.030 |
Why?
|
| Computers | 1 | 1995 | 593 | 0.030 |
Why?
|
| Pentetic Acid | 1 | 1993 | 209 | 0.030 |
Why?
|
| Prostheses and Implants | 2 | 1997 | 1271 | 0.030 |
Why?
|
| Ulnar Nerve | 1 | 1993 | 102 | 0.030 |
Why?
|
| Meglumine | 1 | 1993 | 144 | 0.030 |
Why?
|
| Somatomedins | 1 | 1973 | 179 | 0.030 |
Why?
|
| Plastics | 1 | 1993 | 117 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2000 | 1836 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 1993 | 362 | 0.030 |
Why?
|
| Health Expenditures | 1 | 1985 | 2366 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1991 | 10766 | 0.030 |
Why?
|
| Ulna | 1 | 1993 | 134 | 0.030 |
Why?
|
| Chondrocytes | 1 | 1997 | 795 | 0.030 |
Why?
|
| Ligaments, Articular | 2 | 1986 | 302 | 0.030 |
Why?
|
| Menisci, Tibial | 1 | 1994 | 267 | 0.020 |
Why?
|
| Femoral Fractures | 1 | 1996 | 375 | 0.020 |
Why?
|
| Retrospective Studies | 9 | 1997 | 80647 | 0.020 |
Why?
|
| Sulfates | 5 | 1981 | 380 | 0.020 |
Why?
|
| Veins | 2 | 1988 | 768 | 0.020 |
Why?
|
| Physical Examination | 2 | 1995 | 1255 | 0.020 |
Why?
|
| Particle Size | 4 | 2004 | 1648 | 0.020 |
Why?
|
| Australia | 2 | 2006 | 1250 | 0.020 |
Why?
|
| Paralysis | 1 | 1993 | 250 | 0.020 |
Why?
|
| Radiotherapy Dosage | 3 | 1987 | 2898 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 4016 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 1991 | 2206 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2004 | 10090 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 1998 | 823 | 0.020 |
Why?
|
| Rotation | 1 | 1993 | 517 | 0.020 |
Why?
|
| Bone Development | 2 | 1978 | 472 | 0.020 |
Why?
|
| Humerus | 1 | 1993 | 272 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1973 | 569 | 0.020 |
Why?
|
| Antigens | 2 | 1989 | 1443 | 0.020 |
Why?
|
| Data Collection | 1 | 2000 | 3322 | 0.020 |
Why?
|
| Polysaccharides | 3 | 1987 | 1014 | 0.020 |
Why?
|
| Preoperative Care | 4 | 2001 | 2242 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 1995 | 1258 | 0.020 |
Why?
|
| Recovery of Function | 3 | 2006 | 2979 | 0.020 |
Why?
|
| Myositis Ossificans | 1 | 1991 | 77 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1992 | 20568 | 0.020 |
Why?
|
| Materials Testing | 2 | 2004 | 863 | 0.020 |
Why?
|
| Chromatography | 2 | 1983 | 189 | 0.020 |
Why?
|
| Fractures, Bone | 2 | 1993 | 2046 | 0.020 |
Why?
|
| Bone and Bones | 3 | 1974 | 2568 | 0.020 |
Why?
|
| Apatites | 1 | 1968 | 19 | 0.020 |
Why?
|
| Sulfides | 1 | 1990 | 169 | 0.020 |
Why?
|
| Tendons | 1 | 1993 | 558 | 0.020 |
Why?
|
| Cartilage Diseases | 1 | 1990 | 157 | 0.020 |
Why?
|
| Oxyquinoline | 1 | 1988 | 16 | 0.020 |
Why?
|
| Prospective Studies | 6 | 2004 | 54423 | 0.020 |
Why?
|
| Intraoperative Complications | 2 | 1993 | 1166 | 0.020 |
Why?
|
| Indium Radioisotopes | 1 | 1988 | 113 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 1968 | 170 | 0.020 |
Why?
|
| Half-Life | 2 | 1986 | 651 | 0.020 |
Why?
|
| Indium | 1 | 1987 | 47 | 0.020 |
Why?
|
| Thromboembolism | 2 | 1985 | 995 | 0.020 |
Why?
|
| Tritium | 4 | 1990 | 708 | 0.020 |
Why?
|
| Oxygen | 4 | 1974 | 4227 | 0.020 |
Why?
|
| Chick Embryo | 6 | 1974 | 982 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1988 | 343 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1987 | 100 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1987 | 73 | 0.020 |
Why?
|
| Sphingomyelins | 1 | 1988 | 105 | 0.020 |
Why?
|
| Bucladesine | 1 | 1987 | 118 | 0.020 |
Why?
|
| Lymph Nodes | 3 | 1996 | 3465 | 0.020 |
Why?
|
| Stress, Mechanical | 2 | 1986 | 1674 | 0.020 |
Why?
|
| Theophylline | 1 | 1987 | 131 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 1985 | 5337 | 0.020 |
Why?
|
| Organ Culture Techniques | 2 | 1990 | 795 | 0.020 |
Why?
|
| Arthroscopy | 2 | 1994 | 969 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1993 | 1301 | 0.020 |
Why?
|
| Adolescent | 6 | 1997 | 88326 | 0.020 |
Why?
|
| Arthrography | 1 | 1987 | 150 | 0.020 |
Why?
|
| Salmonella typhi | 1 | 1988 | 198 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1988 | 405 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 20100 | 0.020 |
Why?
|
| Postoperative Period | 2 | 2002 | 1814 | 0.020 |
Why?
|
| Disease Models, Animal | 6 | 1999 | 18255 | 0.020 |
Why?
|
| Thymus Gland | 1 | 1990 | 1243 | 0.020 |
Why?
|
| Permeability | 1 | 1988 | 723 | 0.020 |
Why?
|
| Cell Division | 3 | 1990 | 4465 | 0.020 |
Why?
|
| Bone Regeneration | 1 | 1988 | 432 | 0.020 |
Why?
|
| Bone Marrow | 2 | 1993 | 2911 | 0.020 |
Why?
|
| Liver | 3 | 1986 | 7528 | 0.020 |
Why?
|
| Chondroitin | 2 | 1980 | 64 | 0.020 |
Why?
|
| Complement Hemolytic Activity Assay | 1 | 2004 | 9 | 0.020 |
Why?
|
| Synovial Cyst | 1 | 1985 | 35 | 0.020 |
Why?
|
| Manometry | 1 | 1987 | 454 | 0.010 |
Why?
|
| Credentialing | 1 | 1985 | 116 | 0.010 |
Why?
|
| Human Experimentation | 1 | 1985 | 123 | 0.010 |
Why?
|
| Toxicology | 1 | 1965 | 102 | 0.010 |
Why?
|
| Employment | 2 | 1991 | 1118 | 0.010 |
Why?
|
| Nose | 1 | 1988 | 521 | 0.010 |
Why?
|
| Cohort Studies | 4 | 2006 | 41495 | 0.010 |
Why?
|
| Pressure | 1 | 1987 | 1154 | 0.010 |
Why?
|
| Fracture Fixation, Internal | 2 | 1996 | 973 | 0.010 |
Why?
|
| Tissue Culture Techniques | 1 | 1965 | 290 | 0.010 |
Why?
|
| Technetium | 1 | 1984 | 317 | 0.010 |
Why?
|
| Culture Media | 3 | 1990 | 897 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 1983 | 2112 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1995 | 3575 | 0.010 |
Why?
|
| Chemistry | 1 | 1983 | 347 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1983 | 507 | 0.010 |
Why?
|
| Transplantation, Autologous | 2 | 1998 | 2115 | 0.010 |
Why?
|
| Joint Instability | 1 | 1990 | 801 | 0.010 |
Why?
|
| Reference Values | 1 | 1990 | 4920 | 0.010 |
Why?
|
| United States | 5 | 2006 | 72340 | 0.010 |
Why?
|
| Antibodies | 1 | 1990 | 2418 | 0.010 |
Why?
|
| Urologic Diseases | 1 | 1985 | 247 | 0.010 |
Why?
|
| Contracture | 1 | 1985 | 235 | 0.010 |
Why?
|
| Interleukin-1beta | 2 | 1990 | 999 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 847 | 0.010 |
Why?
|
| Bone Demineralization Technique | 1 | 2001 | 27 | 0.010 |
Why?
|
| Thymidine | 2 | 1990 | 299 | 0.010 |
Why?
|
| Quality of Life | 4 | 2004 | 13367 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1965 | 624 | 0.010 |
Why?
|
| Software | 1 | 1995 | 4434 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1993 | 3424 | 0.010 |
Why?
|
| Brachytherapy | 1 | 1989 | 1223 | 0.010 |
Why?
|
| Public Opinion | 1 | 1985 | 484 | 0.010 |
Why?
|
| Naproxen | 2 | 1992 | 100 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1990 | 1809 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1985 | 496 | 0.010 |
Why?
|
| Models, Biological | 4 | 1992 | 9469 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 21355 | 0.010 |
Why?
|
| Polymers | 2 | 1998 | 1616 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1986 | 1668 | 0.010 |
Why?
|
| Femur Head | 1 | 1982 | 297 | 0.010 |
Why?
|
| Age Factors | 2 | 1990 | 18399 | 0.010 |
Why?
|
| Calcium Phosphates | 1 | 2001 | 171 | 0.010 |
Why?
|
| Heparin | 1 | 1968 | 1634 | 0.010 |
Why?
|
| Extremities | 1 | 1966 | 867 | 0.010 |
Why?
|
| Autoradiography | 1 | 1981 | 728 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 1980 | 174 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 2001 | 2088 | 0.010 |
Why?
|
| Health Status | 2 | 1999 | 4077 | 0.010 |
Why?
|
| Kinetics | 1 | 1988 | 6374 | 0.010 |
Why?
|
| Gold Sodium Thiomalate | 1 | 1979 | 10 | 0.010 |
Why?
|
| Hospitals, Proprietary | 1 | 1979 | 39 | 0.010 |
Why?
|
| Ovalbumin | 2 | 1989 | 677 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1991 | 4352 | 0.010 |
Why?
|
| Hospitals, Special | 1 | 1979 | 91 | 0.010 |
Why?
|
| Absorbable Implants | 1 | 2001 | 338 | 0.010 |
Why?
|
| Stifle | 1 | 1998 | 28 | 0.010 |
Why?
|
| Indomethacin | 1 | 1979 | 325 | 0.010 |
Why?
|
| Alloys | 1 | 1999 | 110 | 0.010 |
Why?
|
| Japan | 1 | 2003 | 1378 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1993 | 9319 | 0.010 |
Why?
|
| Electromyography | 1 | 1983 | 1394 | 0.010 |
Why?
|
| Societies, Medical | 1 | 1990 | 3905 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1993 | 8002 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2001 | 638 | 0.010 |
Why?
|
| Periosteum | 1 | 1997 | 139 | 0.010 |
Why?
|
| Osteolysis | 1 | 1999 | 275 | 0.010 |
Why?
|
| Collagen Diseases | 1 | 1976 | 39 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 1997 | 6228 | 0.010 |
Why?
|
| Knee | 1 | 1978 | 279 | 0.010 |
Why?
|
| Research | 1 | 1965 | 1982 | 0.010 |
Why?
|
| Histiocytosis, Sinus | 1 | 1996 | 45 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2001 | 970 | 0.010 |
Why?
|
| Cell Communication | 2 | 1996 | 1657 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1985 | 1881 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1977 | 882 | 0.010 |
Why?
|
| Bone Matrix | 1 | 1996 | 120 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1984 | 1457 | 0.010 |
Why?
|
| Fractures, Closed | 1 | 1996 | 88 | 0.010 |
Why?
|
| Transplants | 1 | 1997 | 206 | 0.010 |
Why?
|
| Lymphadenitis | 1 | 1996 | 99 | 0.010 |
Why?
|
| Fractures, Open | 1 | 1996 | 107 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1993 | 36426 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 6345 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1997 | 945 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1984 | 1407 | 0.010 |
Why?
|
| Phosphoric Acids | 1 | 1974 | 20 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1999 | 1702 | 0.010 |
Why?
|
| Bioprosthesis | 1 | 1998 | 591 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1984 | 2244 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1974 | 149 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 2561 | 0.010 |
Why?
|
| Sulfur Isotopes | 1 | 1973 | 21 | 0.010 |
Why?
|
| Hydroxyproline | 2 | 1974 | 110 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1986 | 5493 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1973 | 306 | 0.010 |
Why?
|
| Hypophysectomy | 1 | 1973 | 114 | 0.010 |
Why?
|
| Group Processes | 1 | 1994 | 228 | 0.010 |
Why?
|
| Ultrafiltration | 1 | 1973 | 49 | 0.010 |
Why?
|
| DNA | 2 | 1997 | 7213 | 0.010 |
Why?
|
| Fibrin | 1 | 1996 | 507 | 0.010 |
Why?
|
| Surface Properties | 1 | 1996 | 1161 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1973 | 297 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1986 | 8633 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1974 | 385 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1973 | 698 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1973 | 664 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 1975 | 483 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 1985 | 3251 | 0.010 |
Why?
|
| Rats | 2 | 2001 | 23741 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1992 | 861 | 0.010 |
Why?
|
| Ribs | 1 | 1973 | 252 | 0.010 |
Why?
|
| Proline | 2 | 1974 | 457 | 0.010 |
Why?
|
| Boston | 1 | 1984 | 9327 | 0.010 |
Why?
|
| Bone Transplantation | 1 | 1996 | 929 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1993 | 1379 | 0.010 |
Why?
|
| Cobalt | 1 | 1990 | 154 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 10508 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 1993 | 823 | 0.010 |
Why?
|
| Chromium | 1 | 1990 | 132 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1973 | 557 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1997 | 1726 | 0.010 |
Why?
|
| International Agencies | 1 | 1990 | 243 | 0.010 |
Why?
|
| Water | 1 | 1975 | 1411 | 0.000 |
Why?
|
| Surgical Flaps | 1 | 1997 | 1671 | 0.000 |
Why?
|
| Child | 1 | 1997 | 80158 | 0.000 |
Why?
|
| Mandible | 2 | 1974 | 753 | 0.000 |
Why?
|
| Perfusion | 1 | 1973 | 1373 | 0.000 |
Why?
|
| Cathepsins | 1 | 1968 | 241 | 0.000 |
Why?
|
| Carrageenan | 1 | 1987 | 71 | 0.000 |
Why?
|
| Prognosis | 2 | 2004 | 29629 | 0.000 |
Why?
|
| Physicians | 1 | 1985 | 4591 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1993 | 2048 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1997 | 4142 | 0.000 |
Why?
|
| Dextran Sulfate | 1 | 1987 | 256 | 0.000 |
Why?
|
| Risk Factors | 3 | 2004 | 74213 | 0.000 |
Why?
|
| Length of Stay | 1 | 1999 | 6426 | 0.000 |
Why?
|
| Ascorbic Acid | 1 | 1968 | 655 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3810 | 0.000 |
Why?
|
| Drug Carriers | 1 | 1989 | 706 | 0.000 |
Why?
|
| Vitamin E | 1 | 1968 | 872 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1968 | 1510 | 0.000 |
Why?
|
| Patient Care Team | 1 | 1975 | 2521 | 0.000 |
Why?
|
| Colloids | 1 | 1983 | 123 | 0.000 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1966 | 339 | 0.000 |
Why?
|
| Radioactivity | 1 | 1983 | 59 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 11076 | 0.000 |
Why?
|
| Models, Anatomic | 1 | 1986 | 683 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1968 | 1803 | 0.000 |
Why?
|
| Fibrosis | 1 | 1989 | 2049 | 0.000 |
Why?
|
| Ovary | 1 | 1986 | 959 | 0.000 |
Why?
|
| Macrophages | 1 | 1996 | 5767 | 0.000 |
Why?
|
| Bone Marrow Cells | 1 | 1968 | 2417 | 0.000 |
Why?
|
| Microspheres | 1 | 1983 | 784 | 0.000 |
Why?
|
| Contrast Media | 1 | 1993 | 5307 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1983 | 672 | 0.000 |
Why?
|
| Shoes | 1 | 1979 | 92 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1985 | 15502 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1996 | 11530 | 0.000 |
Why?
|
| Proteins | 1 | 1973 | 6032 | 0.000 |
Why?
|
| Postoperative Care | 1 | 1983 | 1468 | 0.000 |
Why?
|
| Tissue Extracts | 1 | 1974 | 141 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1983 | 2413 | 0.000 |
Why?
|
| Rheumatoid Factor | 1 | 1974 | 185 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 561 | 0.000 |
Why?
|
| Parathyroid Glands | 1 | 1974 | 518 | 0.000 |
Why?
|
| Leukocytes | 1 | 1974 | 2026 | 0.000 |
Why?
|